Silence Therapeutics (SLN) Liabilities and Shareholders Equity (2023 - 2026)
Silence Therapeutics (SLN) reported Liabilities and Shareholders Equity of $106.41 million for the quarter ended Jun 30, 2026, down 35.6% from $165.23 million a year earlier and down 7.6% from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Silence Therapeutics posted Liabilities and Shareholders Equity of $131.44 million, down 35.1% from the prior year.
- By year, Liabilities and Shareholders Equity came in at $202.64 million in the year ended Dec 31, 2024 (+69.6%) and $119.45 million in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Liabilities and Shareholders Equity in data going back to the quarter ended Dec 31, 2023.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last three quarters, with an average decline of 9.7% over the last four quarters.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $115.12 million (quarter ended Mar 31, 2026), $131.44 million (quarter ended Dec 31, 2025) and $146.79 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Silence Therapeutics | 516.41 Mn | 444.31 Mn | - | 106.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.41 Mn |
| Mar 31, 2026 | 115.12 Mn |
| Dec 31, 2025 | 131.44 Mn |
| Sep 30, 2025 | 146.79 Mn |
| Jun 30, 2025 | 165.23 Mn |
| Mar 31, 2025 | 185.30 Mn |
| Dec 31, 2024 | 202.64 Mn |
| Dec 31, 2023 | 119.45 Mn |
API Access
Silence Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();